USFDA inspects two manufacturing facilities of Shilpa Medicare

11 Mar 2015 Evaluate

The US Food and Drug Administration (USFDA) auditors have inspected two manufacturing facilities of Shilpa Medicare located at Karnataka. The result of the audit has been awaited by the company.

The inspection was carried out at Deosugur Industrial Area, Deosugur, Raichur and other at 100% EOU, Raichur Industrial Growth Centre, Raichur in state of Karnataka.

Shilpa Medicare produces and exports consistently high-quality Active Pharmaceutical Ingredients Fine Chemicals, intermediates, herbal products and speciality chemical products using sophisticated technology, meticulously following international specifications.

Shilpa Medicare Share Price

318.05 -2.30 (-0.72%)
30-Dec-2025 11:50 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1713.15
Dr. Reddys Lab 1268.00
Cipla 1489.20
Zydus Lifesciences 901.60
Lupin 2073.15
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×